Cingulate Inc. (NASDAQ:CINGW) Sees Significant Growth in Short Interest

Cingulate Inc. (NASDAQ:CINGW) was the target of a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 2,467 shares, a growth of 393.4% from the February 12th total of 500 shares. Based on an average daily volume of 32,769 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 32,769 shares, the short-interest ratio is currently 0.1 days.

Cingulate Stock Up 62.9%

Shares of NASDAQ CINGW traded up $0.02 during trading hours on Tuesday, reaching $0.06. The stock had a trading volume of 219,371 shares, compared to its average volume of 55,847. The firm has a 50-day moving average of $0.07 and a 200-day moving average of $0.06. Cingulate has a fifty-two week low of $0.02 and a fifty-two week high of $0.18.

Cingulate Company Profile

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.